Trends Endocrinol Metab. 2005 Sep;16(7):293-9.

Angiotensin receptors: a new role in cancer?

Source

Institut Cochin, CNRS UMR8104-INSERM U567, Departement de Biologie Cellulaire, 22 rue Méchain, 75014 Paris, France.

Abstract

There is increasing evidence that Angiotensin II (AngII), a major regulator of blood pressure and cardiovascular homeostasis, is involved in the regulation of cell proliferation, angiogenesis, inflammation and tissue remodeling, which suggests that this peptide might also play a role in cancer. This review focuses on the expression and function of Angiotensin I-converting enzyme (ACE) and AngII receptors in various aspects of cancer. Recent experimental data suggests that ACE inhibitors and AngII type 1 receptor (AT1R) antagonists have beneficial effects on tumor progression, vascularization and metastasis, and that the AngII type 2 receptor (AT2R) subtype has a potential role in cancer. An overview of the major intracellular signaling pathways associated with AT1R and AT2R activation in cancer cells, as well as in endothelial and inflammatory cells, is presented here.

PMID:: 16061390; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Related citations

Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation. [J Endocrinol. 2006]
Angiotensin II regulates migration in mouse cultured mesangial cells: evidence for the presence of receptor subtype-specific regulation.
Takeuchi Y, Yamauchi K, Nakamura J, Shigematsu S, Hashizume K. J Endocrinol. 2006 Nov; 191(2):361-7.
Review Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. [Curr Vasc Pharmacol. 2004]
Review Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer.
Escobar E, Rodríguez-Reyna TS, Arrieta O, Sotelo J. Curr Vasc Pharmacol. 2004 Oct; 2(4):385-99.
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. [J Am Coll Surg. 2007]
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ. J Am Coll Surg. 2007 May; 204(5):996-1005; discussion 1005-6.
Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. [Cancer Biol Ther. 2007]
Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.
Carl-McGrath S, Ebert MP, Lendeckel U, Röcken C. Cancer Biol Ther. 2007 Aug; 6(8):1218-26. Epub 2007 Aug 10.
Review Manipulating the angiotensin system--new approaches to the treatment of solid tumours. [Expert Opin Biol Ther. 2006]
Review Manipulating the angiotensin system--new approaches to the treatment of solid tumours.
Ino K, Shibata K, Kajiyama H, Nawa A, Nomura S, Kikkawa F. Expert Opin Biol Ther. 2006 Mar; 6(3):243-55.

See reviews... See all...

Cited by 17 PubMed Central articles

Critical review of cancer risk associated with angiotensin receptor blocker therapy. [Vasc Health Risk Manag. 2011]
Critical review of cancer risk associated with angiotensin receptor blocker therapy.
Wuerzner G, Burnier M, Waeber B. Vasc Health Risk Manag. 2011; 7:741-7. Epub 2011 Dec 12.
A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells. [Int J Pept. 2012]
A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells.
Rodrigues-Ferreira S, Morel M, Reis RI, Cormier F, Baud V, Costa-Neto CM, Nahmias C. Int J Pept. 2012; 2012:745027. Epub 2011 Dec 6.
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. [CMAJ. 2011]
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.
Yoon C, Yang HS, Jeon I, Chang Y, Park SM. CMAJ. 2011 Oct 4; 183(14):E1073-84. Epub 2011 Aug 29.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Angiotensin receptors: a new role in cancer?
Angiotensin receptors: a new role in cancer?
Trends Endocrinol Metab. 2005 Sep ;16(7):293-9.

PubMed
A multicenter, randomized, clinical trial of hormonal therapy in the prevention ...
A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia.
Gastroenterology. 2001 Nov ;121(5):1073-9.

PubMed
Does amlodipine increase cancer incidence?
Does amlodipine increase cancer incidence?
Circulation. 2001 Jul 10 ;104(2):E5.

PubMed
Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates...
Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity.
Proc Natl Acad Sci U S A. 1999 Mar 2 ;96(5):2538-42.

PubMed
Candesartan in heart failure--assessment of reduction in mortality and morbidity...
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
J Card Fail. 1999 Sep ;5(3):276-82.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Angiotensin receptors: a new role in cancer?

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Cited by 17 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information